Found: 5
Select item for more details and to access through your institution.
Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. E75, doi. 10.1002/ajh.26429
- By:
- Publication type:
- Article
Clinical management of a Nigerian patient affected by sickle cell disease with rare blood group and persistent SARS-CoV-2 positivity.
- Published in:
- EJHaem, 2020, v. 1, n. 1, p. 1, doi. 10.1002/jha2.53
- By:
- Publication type:
- Article
Survival of multiple myeloma patients in the era of novel therapies confirms the improvement in patients younger than 75 years: a population-based analysis.
- Published in:
- British Journal of Haematology, 2013, v. 163, n. 1, p. 40, doi. 10.1111/bjh.12465
- By:
- Publication type:
- Article
A real‐world efficacy and safety analysis of combined carfilzomib, lenalidomide, and dexamethasone (KRd) in relapsed/refractory multiple myeloma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 1, p. 41, doi. 10.1002/hon.2820
- By:
- Publication type:
- Article
Dismal outcome of T-cell lymphoma patients failing first-line treatment: results of a population-based study from the Modena Cancer Registry.
- Published in:
- 2015
- By:
- Publication type:
- journal article